A randomized, double-blind, phase 3 trial of maintenance with selixexor/placebo after combination chemotherapy for patients with advanced or recurrent endometrial cancer.
Trial Number
ClinicalTrials.gov Identifier: NCT03555422Contact Person
Status
Closed to Recruitment
Disease Site
Endometrial
Lead Cooperative Group
Participating Groups
GOG-F
CEEGOG
ISGO
GEICO
MITO
NOGGO